These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26849775)

  • 61. Contribution of intramacrophage stages to Pseudomonas aeruginosa infection outcome in zebrafish embryos: insights from mgtC and oprF mutants.
    Hajjar H; Berry L; Wu Y; Touqui L; Vergunst AC; Blanc-Potard AB
    Sci Rep; 2024 Mar; 14(1):6297. PubMed ID: 38491095
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Selective enrichment of mycobacterial proteins from infected host macrophages.
    Chande AG; Siddiqui Z; Midha MK; Sirohi V; Ravichandran S; Rao KV
    Sci Rep; 2015 Aug; 5():13430. PubMed ID: 26303024
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Investigating function roles of hypothetical proteins encoded by the Mycobacterium tuberculosis H37Rv genome.
    Yang Z; Zeng X; Tsui SK
    BMC Genomics; 2019 May; 20(1):394. PubMed ID: 31113361
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of MgtC on the Fitness of
    Li P; Wang H; Sun W; Ding J
    Pathogens; 2023 Dec; 12(12):. PubMed ID: 38133312
    [No Abstract]   [Full Text] [Related]  

  • 65. Cholesterol acquisition by Mycobacterium tuberculosis.
    Larrouy-Maumus G
    Virulence; 2015; 6(5):412-3. PubMed ID: 26126122
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The
    Park M; Kim H; Nam D; Kweon DH; Shin D
    Front Microbiol; 2019; 10():2831. PubMed ID: 31866990
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Investigate Natural Product Indolmycin and the Synthetically Improved Analogue Toward Antimycobacterial Agents.
    Yang Y; Xu Y; Yue Y; Wang H; Cui Y; Pan M; Zhang X; Zhang L; Li H; Xu M; Tang Y; Chen S
    ACS Chem Biol; 2022 Jan; 17(1):39-53. PubMed ID: 34908399
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synthesis and evaluation of a selective fluorogenic Pup derived assay reagent for Dop, a potential drug target in Mycobacterium tuberculosis.
    Merkx R; Burns KE; Slobbe P; El Oualid F; El Atmioui D; Darwin KH; Ovaa H
    Chembiochem; 2012 Sep; 13(14):2056-60. PubMed ID: 22927162
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Study of the Rv1417 and Rv2617c Membrane Proteins and Their Interactions with Nicotine Derivatives as Potential Inhibitors of Erp Virulence-Associated Factor in
    Aguilar-Pineda JA; Febres-Molina C; Cordova-Barrios CC; Campos-Olazával LM; Del-Carpio-Martinez BA; Ayqui-Cueva F; Gamero-Begazo PL; Gómez B
    Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830617
    [TBL] [Abstract][Full Text] [Related]  

  • 70. High-Throughput Screening for Bacterial Glycosyltransferase Inhibitors.
    El Qaidi S; Zhu C; McDonald P; Roy A; Maity PK; Rane D; Perera C; Hardwidge PR
    Front Cell Infect Microbiol; 2018; 8():435. PubMed ID: 30619781
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Structure-Guided Designing and Evaluation of Peptides Targeting Bacterial Transcription.
    Kaur G; Kapoor S; Kaundal S; Dutta D; Thakur KG
    Front Bioeng Biotechnol; 2020; 8():797. PubMed ID: 33014990
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interaction between antimicrobial peptides and mycobacteria.
    Gutsmann T
    Biochim Biophys Acta; 2016 May; 1858(5):1034-43. PubMed ID: 26851776
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Structure and Functional Properties of the Active Form of the Proteolytic Complex, ClpP1P2, from Mycobacterium tuberculosis.
    Li M; Kandror O; Akopian T; Dharkar P; Wlodawer A; Maurizi MR; Goldberg AL
    J Biol Chem; 2016 Apr; 291(14):7465-76. PubMed ID: 26858247
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Resistance related metabolic pathways for drug target identification in Mycobacterium tuberculosis.
    Cloete R; Oppon E; Murungi E; Schubert WD; Christoffels A
    BMC Bioinformatics; 2016 Feb; 17():75. PubMed ID: 26856535
    [TBL] [Abstract][Full Text] [Related]  

  • 75. PE11, a PE/PPE family protein of Mycobacterium tuberculosis is involved in cell wall remodeling and virulence.
    Singh P; Rao RN; Reddy JR; Prasad RB; Kotturu SK; Ghosh S; Mukhopadhyay S
    Sci Rep; 2016 Feb; 6():21624. PubMed ID: 26902658
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nontuberculous Mycobacterial Infections in Cystic Fibrosis.
    Martiniano SL; Nick JA; Daley CL
    Clin Chest Med; 2016 Mar; 37(1):83-96. PubMed ID: 26857770
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Modulation of Virulence Gene Expression in Salmonella enterica subsp. enterica typhimurium by Synthetic Milk-Derived Peptides.
    Ali E; LaPointe G
    Probiotics Antimicrob Proteins; 2022 Aug; 14(4):690-698. PubMed ID: 35380388
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Small Proteins; Big Questions.
    Gray T; Storz G; Papenfort K
    J Bacteriol; 2022 Jan; 204(1):e0034121. PubMed ID: 34309401
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synthetic hydrophobic peptides derived from MgtR weaken Salmonella pathogenicity and work with a different mode of action than endogenously produced peptides.
    Olvera MR; Garai P; Mongin G; Vivès E; Gannoun-Zaki L; Blanc-Potard AB
    Sci Rep; 2019 Oct; 9(1):15253. PubMed ID: 31649255
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In Vivo Methods to Study Protein-Protein Interactions as Key Players in
    Veyron-Churlet R; Locht C
    Pathogens; 2019 Oct; 8(4):. PubMed ID: 31581602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.